The Israeli company EarlySense is a passive contactless bedside sensor company whose sensors continuously monitor respiratory rate, heart rate and exercise. It has recently raised $20 million, half of which comes from Samsung. Other investments include Welch Allyn, which licenses EarlySense sensors, as well as Pitango Venture Captial, JK&B, Proseed and Noaber.

Release date: 2015-01-23

The Israeli company EarlySense is a passive contactless bedside sensor company whose sensors continuously monitor respiratory rate, heart rate and exercise. It has recently raised $20 million, half of which comes from Samsung. Other investments include Welch Allyn, which licenses EarlySense sensors, as well as Pitango Venture Captial, JK&B, Proseed and Noaber.

Company CEO Avner Halperin told MobiHealthNews: "The technology we develop is used to monitor patients in hospitals or long-term care facilities, reduce patient time in hospitals, reduce care costs and increase the safety and effectiveness of care. We plan to market Responding to increasing demand and increasing our share of this sector. Our financing is for this purpose, and the second goal is to extend our technology to the home digital health and wellness sector through our main partner, Samsung. Samsung also participated in this round of financing."

Samsung has been in contact with EarlySense for a long time, and Samsung is also interested in introducing this technology from the clinical to the consumer sector.

EarlySense doesn't want to produce its own consumer-grade devices directly, but just wants to be a sensor manufacturer. Samsung wants to be a consumer equipment manufacturer. At the same time, the price per bed for hospital equipment solutions is typically on the order of thousands of dollars, while household consumer equipment is often at the level of hundreds of dollars.

After this round of financing, EarlySense's total funding is at least $48 million. The company received two new FDA licenses earlier this year, one for an upgraded version of its bed sensor and one for a chair sensor license.

The company's CEO also said that the company saw great value in its technology in the field of household consumption and data medical. The technology was developed and validated in the context of hospitals and home healthcare facilities, and the technology will now demonstrate the same capabilities in the home environment. In fact, the technology is completely untouchable, and people don't need to make any changes to their lifestyle. Devices can have a variety of applications, which are smart devices, improve sleep, and allow older people to stay at home and watch children safely and conveniently. Collecting the analyzed data at the same time will improve you and make your family respond to how you do it.

Source: Science and Technology Medical Network

Extract Powder

China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer

Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.apipepdites.com